Favourable safety and tolerability profile of coadministered amlodipine and atorvastatin in patients with concomitant hypertension and dyslipidemia: Results from the respond trial

被引：0
|
作者：
Preston, R. A.
Jukema, J. W.
Harvey, P.
Sun, F.
Tarasenko, L.
机构：
[1] Univ Miami, Miller Sch Med, Div Clin Pharmacol & Pharmacokinet, Miami, FL 33152 USA
[2] Leiden Univ, Med Ctr, Dept Cardiol C5 P, Leiden, Netherlands
[3] Crouch Oak Family Practice, Addlestone, Surrey, England
[4] Pfizer Inc, New York, NY USA
来源：
JOURNAL OF HYPERTENSION | 2006年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：S82 / S83
页数：2
相关论文
共 50 条
  • [41] Long-term safety profile of bosentan in patients with systemic sclerosis and pulmonary arterial hypertension: Results from the TRAX database
    Denton, CP
    Coghlan, J
    Black, CM
    Hoeper, MM
    Kiely, DG
    Carlsen, J
    Van Lierop, C
    Humbert, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 294 - 294
  • [42] Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomized, controlled trial
    Bodemer, C.
    Kaszuba, A.
    Kingo, K.
    Tsianakas, A.
    Morita, A.
    Rivas, E.
    Papanastasiou, P.
    Keefe, D.
    Patekar, M.
    Charef, P.
    Zhang, L.
    Cafoncelli, S.
    Papavassilis, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2021, 35 (04) : 938 - 947
  • [43] Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial
    Berman, Gary
    Mullin, Kathleen
    Pavlovic, Jelena
    Smith, Timothy
    Croop, Robert
    Madonia, Jennifer
    Mosher, Linda
    Hould, Jennifer
    Lipton, Richard
    NEUROLOGY, 2023, 100 (17)
  • [44] Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
    Galie, Nazzareno
    Gaine, Sean
    Channick, Richard
    Coghlan, J. Gerry
    Hoeper, Marius M.
    Lang, Irene M.
    McLaughlin, Vallerie V.
    Lassen, Cheryl
    Rubin, Lewis J.
    Hsu Schmitz, Shu-Fang
    Sitbon, Olivier
    Tapson, Victor F.
    Chin, Kelly M.
    ADVANCES IN THERAPY, 2022, 39 (01) : 796 - 810
  • [45] Long-Term Safety and Tolerability of a New Formulation of Epoprostenol in Pulmonary Arterial Hypertension (PAH) Patients: Final Results from EPITOME-2
    Granton, J.
    Bergot, E.
    Boonstra, A.
    Subias, P. E.
    Galie, N.
    Langleben, D.
    Lemarie, J. C.
    Pfister, T.
    Simonnau, G.
    Sitbon, O.
    Delcroix, M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04) : S358 - S359
  • [46] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
    Souza, Rogerio
    Delcroix, Marion
    Galie, Nazzareno
    Jansa, Pavel
    Mehta, Sanjay
    Pulido, Tomas
    Rubin, Lewis
    Sastry, B. K. S.
    Simonneau, Gerald
    Sitbon, Olivier
    Torbicki, Adam
    Boyanova, Neli
    Chamitava, Liliya
    Stein, Claudia
    Channick, Richard N.
    ADVANCES IN THERAPY, 2022, 39 (09) : 4374 - 4390
  • [47] Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension
    Nazzareno Galiè
    Sean Gaine
    Richard Channick
    J. Gerry Coghlan
    Marius M. Hoeper
    Irene M. Lang
    Vallerie V. McLaughlin
    Cheryl Lassen
    Lewis J. Rubin
    Shu-Fang Hsu Schmitz
    Olivier Sitbon
    Victor F. Tapson
    Kelly M. Chin
    Advances in Therapy, 2022, 39 : 796 - 810
  • [48] Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open- label Safety Trial
    Berman, G.
    Mullin, K.
    Pavlovic, J.
    Smith, T.
    Croop, R.
    Mosher, L.
    Hould, J.
    Lipton, R.
    HEADACHE, 2023, 63 : 145 - 145
  • [49] Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
    Rogério Souza
    Marion Delcroix
    Nazzareno Galié
    Pavel Jansa
    Sanjay Mehta
    Tomás Pulido
    Lewis Rubin
    B. K. S. Sastry
    Gérald Simonneau
    Olivier Sitbon
    Adam Torbicki
    Neli Boyanova
    Liliya Chamitava
    Claudia Stein
    Richard N. Channick
    Advances in Therapy, 2022, 39 : 4374 - 4390
  • [50] Results of a multicenter, 8-week, parallel-group, randomized, double-blind, double-dummy, phase III clinical trial to evaluate the efficacy and tolerability of amlodipine maleate versus amlodipine besylate in Korean patients with mild to moderate hypertension
    Park, S
    Chung, N
    Kwon, J
    Yoon, JH
    Kim, YJ
    Han, DS
    Kim, HS
    CLINICAL THERAPEUTICS, 2005, 27 (04) : 441 - 450
12345